Vetoquinol corporate brochure 2017

Achieve more together 16 UNE DYNAMIQUE DE CROISSANCE 2016 HIGHLIGHTS LAUNCH OF CALF LYTE PLUS With the launch of CALF LYTE ® PLUS , Vetoquinol continues to help vets and breeders manage neo- natal diarrhoea among livestock. Neonatal diarrhoea most often occurs in the first 4 weeks after birth, and has major economic consequences for the breeder (mortality, cost of care, stunted growth, etc.). THE FIRST VETERINARY PHARMACEUTICAL LABORATORY TO RECEIVE ISO-50001 CERTIFICATION FOR ITS MAIN SITE After implementing its energy policy and undergoing 21 months of prepara- tion, the Vetoquinol Group has officially received ISO-50001 certification for its Lure site; the Group’s main production facility and headquarters. This volun- tary undertaking-unique in the animal health sector-is based on the principle of continuous improvement, which is of great importance to Vetoquinol. Vetoquinol Poland organized several cardiology conferences around UPCARD ® , an innovative medicine for treating dogs with heart disease, in Warsaw, Cracow, Poznan, and Gdansk in February and April. The events were attended by more than 500 veterinarians; a great success! VETOQUINOL POLAND ORGANIZES CARDIOLOGY CONFERENCES FOR UPCARD